RAC 1.11% $1.83 race oncology ltd

RAC has tested three other FTO inhibitors (brequinsr, FB23-2 and...

  1. 8,371 Posts.
    lightbulb Created with Sketch. 1379
    RAC has tested three other FTO inhibitors (brequinsr, FB23-2 and DAC51) on human heart cells in vitro and proved that being an FTO inhibitor isn't sufficient to be a cardio-protector (RAC announcements of 22 November 2021 and 8 December 2021).

    So yes, bisantrene's cardio-protection MOA is different to.its FTO MOA. Which makes it very special.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83
Change
0.020(1.11%)
Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.